Independent Grant Process

Pfizer is continuously striving to improve its process with the goal of ensuring regulatory compliance while providing independent grants to support initiatives that accelerate the translation of clinical science into quality patient care.

Track 1 – Healthcare Quality Improvement & Education

The 2013 Strategic Global Priorities for Healthcare Quality Improvement & Education are:

Vaccines
Oncology
Pain & Inflammation
Infectious Disease
Women's Health

RFPs will be posted on the website. In addition, they will also be disseminated through e-mail to all registered organizations. IGL&C expects to release 2-3 RFPs per clinical area per year.

Track 2 – Annual Meetings (Emerging Science/Knowledge Exchange)

Eligible providers can request funding to support LIVE activities at major national and regional conferences and congresses. CLICK HERE to view the 2013 clinical areas of interest and goals for Track 2.

Clinical Areas Reviewed through Joint Alliances/Partnerships

Thrombosis Prevention / Anti-coagulation

Pfizer and Bristol Myers Squibb (BMS) are working together on grants in support of thrombosis /anticoagulation-related education. The goal of this education is to decrease the unmet medical needs in the prevention and treatment of venous and arterial thrombosis.

Organizations eligible to apply for grants include hospitals, academic medical centers, schools of nursing or pharmacy, professional societies and associations. Pfizer Medical Education Group does not provide direct funding to Medical Education and Communication Companies and therefore, requests from these organizations are not reviewed through our Joint Alliance. For further information on Pfizer's policies or for any questions, please contact Pfizer's Medical Education Group via email at mededgrants@pfizer.com. All grant applications should be submitted to Bristol Myers Squibb only. Please refer to the Bristol Myers Squibb website for information.

Organizations Eligible to Receive Grants and Process Overview

Pfizer is committed to supporting healthcare quality improvement initiatives, continuing professional development and other independent education activities, including CME/CE, that are most likely to improve patient health, and believe that the likelihood of improving patient health increases when education is integrated with quality.

We believe commercial support should be aligned with the literature on effective continuing education for health professionals, and the highest level of standards endorsed by the medical community such as those found in the 2006 ACCME criteria.

Patients are best served when commercial support is provided to those organizations that are engaged in patient care or represent those who deliver patient care. These organizations are in the best position to achieve the highest recognized standards of quality in the medical profession today.

We continue to support proposals that include services from other stakeholder groups as we believe many of these organizations provide a valuable and often essential supportive role that is valued by the medical profession.

Types of organizations eligible to apply for grants include hospitals, academic medical centers, schools of nursing or pharmacy, professional societies and associations, and other institutions specializing in specific healthcare-related disciplines (e.g., public health, quality improvement).

View the full description of the grant application process.

Policies

Throughout the year Independent Grants for Learning & Change (IGL&C), formerly Medical Education Group (MEG), may send out communications directly to registered users of the Pfizer Grant Management System (GMS) with regard to important and time-sensitive topics (e.g., change in policy, changes in process or procedures, system enhancements). Such communications are posted below for your reference in descending chronological order.

In addition to announcements prepared by IGL&C, posted below you will find other reference materials such as our response to the ACCME in September regarding the June 2008 Policy Announcement and Request for Comments.

Date Posted	Description	Link
04/08/13	Pfizer IGL&C announces new name
01/02/13	NEW online Grant Management System
02/07/12	FAQ about new model
01/03/12	Pfizer MEG announces new model
12/27/11	Seeking nominations for External Review Panel Members
03/25/11	Pfizer Medical Education Group — King integration
11/04/09	Pfizer's support of ACCME Transparency Statement
10/20/09	Pfizer Medical Education Group – integration
02/03/09	Change in policy regarding direct funding by Pfizer Medical Education Group to non-U.S. based organizations
12/03/08	Change in Pfizer's CME Grant Policy pursuant to state Attorneys General settlement-CME faculty with promotional speaking involvement
9/15/08	Pfizer's response to ACCME Call for Comments
8/27/08	NEW quarterly competitive grant review process
7/18/08	Statement on Pfizer's recent policy change re CME support
7/18/08	FAQs re Pfizer's recent policy change re CME support
7/02/08	Pfizer announces policy change re CME support

Text SizeAAA

Apply for a grant or view the status of your existing application.

Track 1 - Healthcare Quality Improvement & Education: Once posted, the RFPs will include all relevant deadlines and dates
Track 2 - Annual Meetings: Review cycles and deadlines associated with Track 2-Annual Meeting submissions

Copyright © 2002–2013 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc. is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.